{
  "id": 12983,
  "label": "juvenile myelomonocytic leukemia",
  "model": {
    "label": "Mondo Disease Ontology (MONDO)",
    "source": 0
  },
  "type_id": 0,
  "reference_id": "MONDO:0011908",
  "properties": {
    "xrefs": [
      "DOID:0050458",
      "EFO:1000309",
      "GARD:0009884",
      "ICD10CM:C93.3",
      "ICDO:9946/3",
      "MEDGEN:138109",
      "MESH:D054429",
      "MedDRA:10023249",
      "NANDO:2200014",
      "NANDO:2200015",
      "NCIT:C9233",
      "NORD:1316",
      "OMIM:607785",
      "ONCOTREE:JMML",
      "Orphanet:86834",
      "SCTID:445227008",
      "UMLS:C0349639",
      "icd11.foundation:1786015803"
    ],
    "synonyms": [
      "chronic myelomonocytic leukaemia",
      "chronic myelomonocytic leukemia",
      "JCML",
      "JMML",
      "juvenile chronic myelogenous leukaemia",
      "juvenile chronic myelogenous leukemia",
      "juvenile chronic myeloid leukaemia",
      "juvenile chronic myeloid leukemia",
      "juvenile chronic myelomonocytic leukaemia",
      "juvenile chronic myelomonocytic leukemia",
      "juvenile myelomonocytic leukemia",
      "juvenile myelomonocytic leukemia, autosomal dominant, somatic mutation",
      "leukemia, juvenile myelomonocytic, autosomal dominant, somatic mutation",
      "leukemia, juvenile myelomonocytic, somatic",
      "leukemia, chronic myelomonocytic",
      "leukemia, juvenile myelomonocytic"
    ],
    "categories": [
      {
        "ref": "MONDO:0002081",
        "name": "musculoskeletal system disorder"
      },
      {
        "ref": "MONDO:0003900",
        "name": "connective tissue disorder"
      },
      {
        "ref": "MONDO:0005046",
        "name": "immune system disorder"
      },
      {
        "ref": "MONDO:0005570",
        "name": "hematologic disorder"
      }
    ],
    "definition": "A myelodysplastic/myeloproliferative neoplasm of childhood that is characterized by proliferation principally of the granulocytic and monocytic lineages. Myelomonocytic proliferation is seen in the bone marrow and the blood. The leukemic cells may infiltrate any tissue, however liver, spleen, lymph nodes, skin, and respiratory tract are the most common sites of involvement. (WHO, 2001)"
  },
  "isLeaf": true,
  "isRoot": false,
  "child_count": 0,
  "parents": [
    {
      "id": 19790,
      "label": "chronic myelomonocytic leukemia",
      "isLeaf": false,
      "isRoot": false,
      "parents": [
        3274,
        7847,
        19728
      ],
      "type_id": 0,
      "properties": {
        "xrefs": [
          "DOID:0080188",
          "EFO:1001779",
          "GARD:0008225",
          "ICD10CM:C93.1",
          "ICDO:9945/3",
          "MEDGEN:44125",
          "MESH:D015477",
          "MedDRA:10009018",
          "NANDO:2200014",
          "NCIT:C3178",
          "ONCOTREE:CMML",
          "Orphanet:98823",
          "SCTID:127225006",
          "UMLS:C0023480",
          "icd11.foundation:2073226578"
        ],
        "synonyms": [
          "CMML",
          "chronic myelomonocytic leukaemia (CMML)",
          "chronic myelomonocytic leukemia",
          "chronic myelomonocytic leukemia (CMML)"
        ],
        "categories": [
          {
            "ref": "MONDO:0002081",
            "name": "musculoskeletal system disorder"
          },
          {
            "ref": "MONDO:0003900",
            "name": "connective tissue disorder"
          },
          {
            "ref": "MONDO:0005046",
            "name": "immune system disorder"
          },
          {
            "ref": "MONDO:0005570",
            "name": "hematologic disorder"
          }
        ],
        "definition": "A myelodysplastic/myeloproliferative neoplasm which is characterized by persistent monocytosis, absence of a Philadelphia chromosome and BCR/ABL fusion gene, fewer than 20 percent blasts in the bone marrow and blood, myelodysplasia, and absence of PDGFRA or PDGFRB rearrangement."
      },
      "child_count": 3,
      "reference_id": "MONDO:0020311"
    }
  ],
  "children": [],
  "roots": [
    {
      "id": 19790,
      "label": "chronic myelomonocytic leukemia"
    }
  ]
}